2006
DOI: 10.1161/circulationaha.105.568162
|View full text |Cite
|
Sign up to set email alerts
|

Extracellular Matrix Metalloproteinase Inducer Regulates Matrix Metalloproteinase Activity in Cardiovascular Cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

9
156
0
4

Year Published

2011
2011
2017
2017

Publication Types

Select...
5
1
1

Relationship

1
6

Authors

Journals

citations
Cited by 155 publications
(169 citation statements)
references
References 28 publications
9
156
0
4
Order By: Relevance
“…[19][20][21][22][23][24] Recent studies provide evidence that CyPA is also present in the cytoplasm of platelets and can be released from granules upon platelet activation to bind to endothelial cells, monocytes, and macrophages via the CyPA receptor EMMPRIN (CD147), thereby inducing a signaling cascade into the target cell (eg, degranulation or expression of matrix metalloproteinases. 19,23,[25][26][27][28] The function of intracellular CyPA in platelets has not yet been explored.In the present study, we show for the first time that CyPA deficiency leads to multiple platelet activation defects caused by strongly reduced Ca 2ϩ mobilization from intracellular stores and Ca 2ϩ entry from the extracellular space. Our results identify CyPA as a powerful Ca 2ϩ regulator in platelets.…”
mentioning
confidence: 99%
“…[19][20][21][22][23][24] Recent studies provide evidence that CyPA is also present in the cytoplasm of platelets and can be released from granules upon platelet activation to bind to endothelial cells, monocytes, and macrophages via the CyPA receptor EMMPRIN (CD147), thereby inducing a signaling cascade into the target cell (eg, degranulation or expression of matrix metalloproteinases. 19,23,[25][26][27][28] The function of intracellular CyPA in platelets has not yet been explored.In the present study, we show for the first time that CyPA deficiency leads to multiple platelet activation defects caused by strongly reduced Ca 2ϩ mobilization from intracellular stores and Ca 2ϩ entry from the extracellular space. Our results identify CyPA as a powerful Ca 2ϩ regulator in platelets.…”
mentioning
confidence: 99%
“…Extracellular matrix metalloproteinase inducer (EMM-PRIN) triggers the synthesis of MMP-9 in a paracrine or autocrine manner (Zhou et al, 2005;Schmidt et al, 2006). Increasing evidence shows that in response to certain proatherogenic stimuli such as oxLDL, EMMPRIN is upregulated strongly in atherosclerosis-related cells, including macrophages and coronary smooth muscle cells (Major et al, 2002;Haug et al, 2004;Schmidt et al, 2006).…”
mentioning
confidence: 99%
“…Increasing evidence shows that in response to certain proatherogenic stimuli such as oxLDL, EMMPRIN is upregulated strongly in atherosclerosis-related cells, including macrophages and coronary smooth muscle cells (Major et al, 2002;Haug et al, 2004;Schmidt et al, 2006). It also increases in activated platelets and mediated NF-jB activation by inducing the production of MMP-9, IL-6, and TNF-a (Schmidt et al, 2008).…”
mentioning
confidence: 99%
“…Максимально повышенное содержание гликоза-миногликанов в первые трое суток при остром инфар-кте миокарда свидетельствует о деструктивных про-цессах во внеклеточном матриксе миокарда [6]. На 10-12 сутки отмечается высокое содержание фибронектина, пептидно-связанного оксипролина, снижение уровня гликозаминогликанов.…”
Section: Discussionunclassified
“…Как известно, после гибели кардиомиоцитов при ИМ репарация осуществляется за счет соединитель-ной ткани, в состав которой входят клеточные эле-менты (фибробласты) и внеклеточный матрикс [6]. Регуляция синтеза и распада белков внеклеточного мактрикса осуществляется системой матриксных металлопротеиназ и ее тканевых ингибиторов [1,7].…”
unclassified